Kalypso Wellness Centers partner with South Texas Mental Health Associates to offer Kalypso Ketamine® infusion treatments in Corpus Christi
San Antonio, Texas (April 2, 2019) — Kalypso Wellness Centers continues to reach new milestones as they proudly announce they have now collectively administered 5,000 of their patent pending Kalypso Ketamine® infusions. To date, they have treated patients suffering from more than 32 disease states including chronic pain, PTSD, migraine headaches, depression and fibromyalgia. Since the company’s inception in 2016, they have expanded to two corporate sites and four managed locations in three different states – Mississippi, New York and Texas – and are looking to announce more locations in the next few months.
“We remain humble and grateful for our clinic partners, our referring physicians, and most importantly the patients who trust in our therapies,” said Ryan Bridges, Kalypso Wellness Centers Chief Operating Officer. “Due to our excellent clinical results, we believe our therapies have extended applications across an even broader range of patient conditions. We hope this will lead to greater penetration and adoption of low dose ketamine infusions as an alternative method of treatment for many diseases.”
As the popularity of low dose ketamine infusions continues, more and more “pop up clinics” are coming onto the scene. This means consumers really need to do their research before investing in the infusions. With low dose ketamine infusions becoming more mainstream, Kalypso Wellness Centers are committed to staying at the forefront of the conversation around proper evaluation, administration and follow up care in order to make sure patients are truly getting the care they so desperately need and deserve.
“We started this company to help patients who were frustrated with their clinical progress,” Dr. Cannon Clifton , Kalypso Wellness Center’s CEO and Founder explains. “As we reach the 5,000 infusion milestone, we believe we are just getting started. Personally, treating patients at Kalypso Wellness Centers has been the most satisfying aspect of my medical career.”
Kalypso Wellness Centers was founded by two board-certified anesthesiologists and two board-certified pain management physicians with 50 years of total experience. Their treatments have demonstrated efficacy rates of 90% with less than 5% of patients experiencing any adverse reactions. All infusions are medically supervised and their team of doctors pride themselves on working collaboratively with the patient’s primary care physician or mental health provider to treat the patient as a whole.
Unlike at other clinics, Kalypso uses five distinct proprietary ketamine formulations to create an individualized approach to the patient’s symptoms. Traditionally known as an anesthetic or recreational drug, research conducted at Yale University, the National Institute of Health, Johns Hopkins and others has shown Ketamine’s positive benefits as an alternative method for treating depression and managing pain. The drug essentially works by resetting a brain’s neural pathways, thus stopping the problem at its source.
As the company continues to expand, the company’s research team led by Dr. Bryan Clifton, Kalypso Wellness Centers Chief Medical Officer, continues to research a variety of medications and formulations to better optimize their treatments and identify new symptoms that ketamine could positively affect.
For more information, visit kalypsowellness.com
About Kalypso Wellness Centers
Kalypso Wellness Centers was formed in 2016 by two board certified anesthesiologists Dr. Cannon and Dr. Bryan Clifton as well as two board certified pain management physicians, Dr. Mark Moran and Dr. Scott Worrich, who were tired of seeing patients needlessly suffering and chronically debilitated on prescription narcotics. After countless months of research, they found a promising new solution with the use of ketamine infusions that could be offered to patients. As treatments continued, they created the RESET Ketamine Therapy™, which includes five distinct proprietary ketamine formulations: KalyCalm®, KalyCan®, KalyMax®, KalyPro® and KalyZen®. Upon further investigation, they discovered that when tailored to each patient’s unique disease state, these infusions can provide a substantial improvement in quality of life for patients with anxiety, major depressive disorder, PTSD, bipolar disorder, fibromyalgia, neuropathic pain, inflammatory pain, chronic pain, and migraines/chronic headaches.
For more information, visit www.kalypsowellness.com— Kalypso Wellness Centers continues to reach new milestones as they proudly announce they have now collectively administered 5,000 of their patent pending Kalypso Ketamine® infusions. To date, they have treated patients suffering from more than 32 disease states including chronic pain, PTSD, migraine headaches, depression and fibromyalgia. Since the company’s inception in 2016, they have expanded to two corporate sites and four managed locations in three different states – Mississippi, New York and Texas – and are looking to announce more locations in the next few months.